1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Meningococcal Immunisation: new trials by email Literature Review of Meningococcal Immunisation trials Research Report on Meningococcal Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents Pentavalent Meningococcal ABCYW vaccine, MenACYW conjugate vaccine, Meningococcal group B vaccine - Meningococcal Immunisation, Healthy Volunteers | Phase 1 / Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1215 | 2023-10-31 | 2026-01-13 |
| Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants Multicomponent Meningococcal B Vaccine, Meningococcal Group B Vaccine MenB, Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed) - Meningococcal Immunisation, Healthy Volunteers | Phase 1 | Terminated | Sanofi Pasteur, a Sanofi Company | 576 | 2021-03-29 | 2025-10-10 |
4CMenB vaccine (2) · MenB-FHbp vaccine (2) · DNA, Recombinant (1) · DNA, Ribosomal (1) · Elements (1) · Meningococcal Vaccines (1)
Sanofi Pasteur, a Sanofi Company (2)
Puerto Rico (2) · United States (2)
2023 (2)